knowledge -WSS

knowledge

author：hotspot 2025-10-01 23:06:06 - browse：88829

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

focus

hotspot

WSS

Physicians aren't 'burning out.' They're suffering from moral injury

Medicare to cover more brain scans related to Alzheimer’s drugs

How I helped Pfizer think through the ethics of Viagra

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

What the Wegovy shortage looks like for doctors — and for patients

A revolution in caring for preterm infants

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

Medicare details structure of new drug price negotiation program

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

In Memoriam: Notable people who died in 2023

FDA scientists endorse Pfizer/BioNTech Covid

The cancer drug shortage isn’t new — and neither are the solutions

Cancer cells are shown to suck energy source from immune cells

Psychedelics group wrestles with new pharma identity

A revolution in caring for preterm infants

Virginia high school admissions case could be legal follow

Cancer cells are shown to suck energy source from immune cells

hotspot

STAT Readout: Today's biotech news includes Sana and Amylyx

'Null' research findings aren't empty of meaning. Let's publish them

Peter Marks talks Operation Warp Speed for Rare Diseases

H.R. 3 is the wrong path to lower drug costs

Takeaways from AdvaMed, the largest medical devices conference

Readout LOUD podcast: Merger Mondays, Ozempic panic

focus

hotspot

focus

knowledge